Esperity is the first multilingual cancer patient community, aiming to empower patients worldwide. The platform allows them to keep track of their health evolution during treatment, list their biomarkers, exchange information with similar patients, and become aware of open clinical trials.
Esperity also connects to wearables, allowing for more objective data to be captured. Aggregated data will be used to understand the relationship between lifestyle and treatment outcomes.
The next step would be coupling with services that provide biomarker measurements. By aggregating individual dynamic data from various sources, Esperity aims to develop a model that can predict treatment efficacy.
